Clinical trial

Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients

NCT01427374

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record below.

Study at a glance

Registry-backed

Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients

Design: OBSERVATIONAL · Status: TERMINATED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2011-05-01

PhaseN/A

Conditions

End Stage Renal Diseaseverified · MONDO: end stage renal failure

Interventions

Sponsors & collaborators

University of Albertalead sponsor

Massachusetts General Hospitalcollaborator

Mapped research locations

BostonMassachusetts, United States1 SeattleWashington, United States1 IndianapolisIndiana, United States1 EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01427374 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.